Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$39,757,733
+$5,579,644 QoQ
Shares Held
156,545
+12.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#506
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $468,730,500 across 16 Drug Manufacturers - General names. JNJ ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
248,532 | $89,998,407 | |
| 2 | LLY |
ELI LILLY & Co
|
65,278 | $78,296,398 | |
| 3 | NVS |
Novartis AG
|
442,978 | $69,423,512 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
156,545 | $39,757,733 | |
| 5 | AZN |
Astrazeneca PLC
|
192,721 | $36,543,756 | |
| 6 | MRK |
Merck & Co., Inc.
|
252,444 | $32,439,054 | |
| 7 | ABBV |
AbbVie Inc.
|
123,655 | $31,116,544 | |
| 8 | GSK |
GSK plc
|
551,436 | $28,906,275 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,757,733 | 156,545 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $34,178,089 | 139,822 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $28,284,684 | 136,674 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $22,487,181 | 121,277 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $16,711,155 | 109,402 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $14,206,186 | 85,662 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $11,448,263 | 79,161 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $11,412,427 | 70,421 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $8,827,333 | 60,395 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,903,565 | 56,284 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $8,107,846 | 51,728 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,891,541 | 50,668 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $8,506,569 | 51,393 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,758,370 | 50,054 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $7,545,251 | 42,713 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,809,244 | 35,561 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $5,102,524 | 28,745 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,579,228 | 14,553 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,108,779 | 12,327 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,708,024 | 10,576 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,904,559 | 11,561 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,731,920 | 10,538 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,453,876 | 9,238 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,383,095 | 9,290 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $983,566 | 6,994 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,216,097 | 16,900 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||